GRI, the supplier of biotechnology instrumentation, has signed an agreement with Guava Technologies to provide cytometry systems to the UK
The agreement will provide British laboratories access to the latest in cutting edge personal cytometry systems designed and manufactured by Guava.
Guava Technologies is changing cellular based analysis by providing integrated solutions to relieve bottlenecks in cell research.
Established in 1998 and based in Hayward, California, Guava has already positioned itself as a truly innovative company facilitating cellular advances throughout the research environment.
Guava's mission is to become a global leader in providing proprietary accessible micro volume single cell analysis systems.
The core technology driving the company forward is the Guava PC, said to be the world's first personal cytometry platform.
This system allows researchers to complete experiments quickly and easily and therefore reduce the time taken to attain results, a trait essential for successful cellular analysis.
The partnership with GRI and more specifically GRI's Cellular Biology division will provide exposure and promotion of Guava Technology systems directly to it's target market, the cell biology laboratory.
The addition of Guava Technologies to the range of sole UK agencies further enhances GRI's position as the premium supplier to the UK biotechnology and cellular biology market place.
